subject: Outsourcing In Drug Development: The Contract Cro Market, 3rd Edition [print this page] Outsourcing in Drug Development: The Contract CRO Market, 3rd Edition
Pages : 250
Driven by mounting market pressures, companies are increasingly implementing outsourcing strategies to increase revenues through faster drug development. By decreasing their in-house facilities and staff, and outsourcing more of their R&D functions, pharmaceutical and biotechnology companies are reshaping the drug development services industry.
Kalorama Information's Outsourcing in Drug Development is the third edition of this study of the drivers for outsourcing drug development, the companies involved in this market and the opportunity for revenues. Part of the CMO Market Series, this volume joins Outsourcing in Drug Discovery, published earlier this year.
As part of its comprehensive coverage of this market, this report contains:
A Detailed Introduction to the Clinical Trial Process
Statistics of Drugs in Development by Phase
Markets and Forecasts for Outsourcing In Drug Development (broken down by AMC, CMO and other)
Main Drivers for Outsourcing in Drug Development
Discussion of Industry and Regulatory Trends
CMO Market Share
Detailed Profiles of CMOs, Contract Laboratories, Clinical Trial Labs and EDC Solution Companies
As part of Kalorama Information's research process, information for this report is gathered from sources including trade press, company reports and government databases. Kalorama Information's analyst also interviewed dozens of experts in the industry to discover new trends and confirm assumptions.
Table of Contents :
CHAPTER ONE: EXECUTIVE SUMMARY
The Drug Development Process
Government Regulation of Clinical Researc
Active Phase I, II & III Clinical Trial
Phase IV Studies: Post Approval
Recruiting for Clinical Trial
The Complexity and Costs Of Clinical Trials Are Increasing
Clinical Trials Worldwide
The Contract Drug Development Industry
R&D Outsourced to Contract Drug Development
Contract Drug Development Market
Trends Affecting Growth of Contract Drug Development Industry
oGlobalization of Drug Development
oRapid Technological Change Increasing Data
oBiotechnology Industry Growth
oIncreased Regulatory Scrutiny
oNeed for Fast, Efficient, and Cost-Effective Drug Development
